Showing results (111-120 of 714) with videos related to
Sort By:
Pageof 72
BMC Medical Genetics|June 3, 2004
Elevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genesConnie E Byrne, Anthony Fitzgerald, Christopher P Cannon, et al.Journal of Thrombosis and Thrombolysis|December 6, 2012
Urinary albumin concentration and long-term cardiovascular risk in acute coronary syndrome patients: a PROVE IT-TIMI 22 substudyBabak Nazer, Kausik K Ray, Sabina A Murphy, et al.American Heart Journal|April 29, 2008
High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysisAmir Lotfi, Marc J Schweiger, Gregory R Giugliano, et al.American Heart Journal|January 25, 2008
Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trialsDalton S McLean, Shmuel Ravid, Michael Blazing, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|August 12, 2009
Identification of genetic variants associated with response to statin therapyJessica L Mega, David A Morrow, Alison Brown, et al.American Heart Journal|January 31, 2006
Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 studyEric E Smith, Christopher P Cannon, Sabina Murphy, et al.Journal of Clinical Lipidology|October 7, 2020
Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)James A Underberg, Christopher P Cannon, Dominique Larrey, et al.Journal of the American College of Cardiology|August 1, 2006
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapyChristopher P Cannon, Benjamin A Steinberg, Sabina A Murphy, et al.Clinical Cardiology|December 29, 2017
The effect of fasting status on lipids, lipoproteins, and inflammatory biomarkers assessed after hospitalization for an acute coronary syndrome: Insights from PROVE IT-TIMI 22Dylan L Steen, Amarachi A Umez-Eronini, Jianping Guo, et al.Critical Pathways in Cardiology|February 17, 2012
Are continuing medical education activities effective in improving the competence and performance of clinicians? Evidence from activities for primary care clinicians who manage patients with acute coronary syndromesJanardhan Sampath, Derek T Dietze, Peter P Toth, et al.Pageof 72